Meprobamate and aspirin and Gall bladder fistula - a phase IV clinical study of FDA data
There is no Gall bladder fistula reported by people who take Meprobamate and aspirin and have side effects.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Meprobamate And Aspirin?
Meprobamate and aspirin has active ingredients of aspirin; meprobamate.
What is Gall Bladder Fistula?
Gall bladder fistula (abnormal connection) is found to be associated with 6 drugs by eHealthMe.
Do you take Meprobamate and aspirin and have Gall bladder fistula?Check whether Gall bladder fistula is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Gall bladder fistula and when was it recovered:
Expand to all the drugs that have ingredients of aspirin; meprobamate:
Alternative drugs to, pros and cons of Meprobamate and aspirin:
Gall bladder fistula treatments and more:
- Gall bladder fistula (1 reports)
COVID vaccines that are related to Gall bladder fistula:
- Gall bladder fistula in Moderna COVID Vaccine
- Gall bladder fistula in Pfizer BioNTech Covid Vaccine
- Gall bladder fistula in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Gall bladder fistula:
All the conditions that are associated with Gall bladder fistula:
How the study uses the data?
The study uses data from the FDA. It is based on aspirin; meprobamate (the active ingredients of Meprobamate and aspirin) and Meprobamate and aspirin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Relafen and Ultrasound Breast Abnormal - 8 seconds ago
- Motrin and Fistula - 10 seconds ago
- Lotrel and Transitional Cell Carcinoma - 11 seconds ago
- Constipation and Peripheral Arterial Occlusive Disease - 11 seconds ago
- Lexiscan and Cimzia drug interaction - 14 seconds ago
- Cefzil and Migraine - 16 seconds ago
- Psoriatic Arthropathy and Coughing Up Blood - 16 seconds ago
- Velphoro and Harvoni drug interaction - 29 seconds ago
- Zolpidem and Renal Haemorrhage - 37 seconds ago
- Coreg Cr and Entresto drug interaction - 37 seconds ago